Mercer Global Advisors Inc Astrazeneca PLC Transaction History
Mercer Global Advisors Inc
- $58.7 Billion
- Q3 2025
A detailed history of Mercer Global Advisors Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Mercer Global Advisors Inc holds 128,967 shares of AZN stock, worth $11.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
128,967
Previous 135,497
4.82%
Holding current value
$11.5 Million
Previous $9.47 Million
4.5%
% of portfolio
0.02%
Previous 0.02%
Shares
26 transactions
Others Institutions Holding AZN
# of Institutions
1,544Shares Held
503MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...